[{"id":"eeb52291-934d-413e-8d6a-d2fd9db1c0f7","acronym":"","url":"https://clinicaltrials.gov/study/NCT00678626","created_at":"2021-01-18T02:32:12.775Z","updated_at":"2024-07-02T16:37:39.298Z","phase":"Phase 2","brief_title":"Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast Cancer","source_id_and_acronym":"NCT00678626","lead_sponsor":"Pfizer","biomarkers":" HER-2","pipe":"","alterations":" ","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e docetaxel • figitumumab (CP-751,871)"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 04/01/2009","start_date":" 04/01/2009","primary_txt":" Primary completion: 09/01/2011","primary_completion_date":" 09/01/2011","study_txt":" Completion: 09/01/2011","study_completion_date":" 09/01/2011","last_update_posted":"2015-05-04"}]